Analysis of mcr family of colistin resistance genes in Gram-negative isolates from a tertiary care hospital in India
Journal of Applied Microbiology · 2024
DOI: 10.1093/jambio/lxae172 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Applied Microbiology, 2024. Verfasst von Dhinakaran Irusan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, The Madras Medical Mission, 4-A, Mogappair, Chennai, Tamil Nadu 600037, India. Hauptthemen laut MEDLINE: Colistin, Tertiary Care Centers, Anti-Bacterial Agents, Microbial Sensitivity Tests. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: ICMR.
Abstract (Originalsprache)
Aim Colistin serves as the drug of last resort for combating numerous multidrug-resistant (MDR) Gram-negative infections. Its efficacy is hampered by the prevalent issue of colistin resistance, which severely limits treatment options for critically ill patients. Identifying resistance genes is crucial for controlling resistance spread, with horizontal gene transfer being the primary mechanism among bacteria. This study aimed to assess the prevalence of plasmid-mediated mcr genes associated with colistin resistance in Gram-negative bacteria, utilizing both genotypic and phenotypic tests. Methods and results The clinical isolates (n = 913) were obtained from a tertiary care center in Chennai, India. Colistin resistance was seen among Gram-negative isolates. These strains underwent screening for mcr-1, mcr-3, mcr-4, and mcr-5 genes via conventional PCR. Additionally, mcr-positive isolates were confirmed through Sanger sequencing and phenotypic testing. The bacterial isolates predominantly comprised Klebsiella pneumoniae (62.43%), Escherichia coli (19.71%), Pseudomonas aeruginosa (10.73%), and Acinetobacter baumannii (4.81%), along with other species. All isolates exhibited multidrug resistance to three or more antibiotic classes. Colistin resistance, determined via broth microdilution (BMD) using CLSI guidelines, was observed in 13.08% of the isolates studied. Notably, mcr-5 was detected in K. pneumoniae in PCR, despite its absence in Sanger sequencing and phenotypic tests (including the combined-disk test, colistin MIC in the presence of EDTA, and Zeta potential assays). This finding underscores the importance of employing multiple diagnostic approaches to accurately identify colistin resistance mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, The Madras Medical Mission, 4-A, Mogappair, Chennai, Tamil Nadu 600037, India.
- Department of Bio & Nano Technology, Nitte (Deemed to be University), Nitte University Centre for Science Education and Research, Paneer Campus, Deralakatte, Mangaluru 575018, India.
- Department of Infectious Diseases & Microbial Genomics, Nitte (Deemed to be University), Nitte University Centre for Science Education and Research, Paneer Campus, Deralakatte, Mangaluru 575018, India.
- Nitte (Deemed to be University), Medical Sciences Complex, Mangaluru 575018, India.
ORCID-Profile: Sadanand Dangari Akshay, Vijaya Kumar Deekshit
Förderung
- ICMR
Zitieren
APA
Irusan, D., Akshay, S. D., Shetty, V. P., Karunasagar, I., Deekshit, V. K., & Rohit, A. (2024). Analysis of mcr family of colistin resistance genes in Gram-negative isolates from a tertiary care hospital in India. Journal of Applied Microbiology. https://doi.org/10.1093/jambio/lxae172
Vancouver
Irusan D, Akshay SD, Shetty VP, Karunasagar I, Deekshit VK, Rohit A. Analysis of mcr family of colistin resistance genes in Gram-negative isolates from a tertiary care hospital in India. Journal of Applied Microbiology. 2024. doi:10.1093/jambio/lxae172
BibTeX
@article{Irusan2024,
author = {Irusan, Dhinakaran and Akshay, Sadanand Dangari and Shetty, Varsha Prakash and Karunasagar, Iddya and Deekshit, Vijaya Kumar and Rohit, Anusha},
title = {Analysis of mcr family of colistin resistance genes in Gram-negative isolates from a tertiary care hospital in India},
journal = {Journal of Applied Microbiology},
year = {2024},
doi = {10.1093/jambio/lxae172}
}
EUVIMED